Surgalign Holdings is a medical technology company. Co. has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. Co. also has a portfolio of orthobiologics, or biomaterials. Co. is developing an Augmented Reality and Artificial Intelligence digital surgery platform called ARAI (referred to ARAI) to enable digital spine surgery. ARAI is designed to automatically segment, identify, and recognize patient anatomy to autonomously assist the surgeon throughout the surgical procedure. The SRGA stock yearly return is shown above.
The yearly return on the SRGA stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2018 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the SRGA annual return calculation with any dividends reinvested as applicable (on ex-dates).
|